Wellington Management Group’s Viridian Therapeutics VRDN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$60.2M	Buy	3,078,554 +1,107,143	+56%	+$32.9M	0.01%	681
2025 Q4	$61.4M	Buy	1,971,411 +848,879	+76%	+$23.3M	0.01%	677
2025 Q3	$24.2M	Buy	1,122,532 +851,989	+315%	+$15.4M	﹤0.01%	952
2025 Q2	$3.78M	Buy	270,543 +21,373	+9%	+$290K	﹤0.01%	1442
2025 Q1	$3.36M	Buy	249,170 +24,686	+11%	+$420K	﹤0.01%	1454
2024 Q4	$4.3M	Sell	224,484 -11,503	-5%	-$250K	﹤0.01%	1381
2024 Q3	$5.37M	Sell	235,987 -48,057	-17%	-$786K	﹤0.01%	1315
2024 Q2	$3.7M	Buy	284,044 +43,215	+18%	+$598K	﹤0.01%	1385
2024 Q1	$4.22M	Buy	240,829 +48,732	+25%	+$945K	﹤0.01%	1365
2023 Q4	$4.18M	Sell	192,097 -23,551	-11%	-$372K	﹤0.01%	1350
2023 Q3	$3.31M	Buy	215,648 +43,349	+25%	+$827K	﹤0.01%	1380
2023 Q2	$4.1M	Buy	172,299 +47,903	+39%	+$1.23M	﹤0.01%	1325
2023 Q1	$3.16M	Buy	124,396 +3,893	+3%	+$125K	﹤0.01%	1394
2022 Q4	$3.52M	Buy	+120,503	New	+$2.78M	﹤0.01%	1366
2021 Q3	–	Sell	-578,560	Closed	-$10.6M	–	2270
2021 Q2	$10.6M	Hold	578,560	–	–	﹤0.01%	1253
2021 Q1	$9.67M	Buy	+578,560	New	+$10.8M	﹤0.01%	1250